Jennifer McCormick
Medical · Neenah, WINPI 1669423323
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in WI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 98 payments — averaging $19.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$320
- Otsuka America Pharmaceutical, Inc.$213
- GSK$195
- AstraZeneca$186
- Aurinia Pharma U.S., Inc.$123
- Akebia Therapeutics Inc$96
- plus $748 from 18 others
What the payments were for
- Food & beverage$1,79896%
- Education$824%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 15 | $320 |
| Otsuka America Pharmaceutical, Inc. | 11 | $213 |
| GSK | 12 | $195 |
| AstraZeneca(2 entities) | 9 | $186 |
| Aurinia Pharma U.S., Inc. | 6 | $123 |
| Akebia Therapeutics Inc | 5 | $96 |
| OPKO Pharmaceuticals, LLC | 5 | $95 |
| Travere Therapeutics, Inc. | 4 | $70 |
| Bayer | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Ardelyx, Inc. | 3 | $55 |
| Vifor Pharma, Inc. | 3 | $54 |
| Fresenius USA Marketing, Inc. | 3 | $46 |
| Daiichi Sankyo Inc. | 1 | $41 |
| Lilly USA, LLC | 2 | $40 |
| Calliditas Therapeutics US Inc. | 2 | $40 |
| Mallinckrodt Hospital Products Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $34 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Cormedix Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
How this compares
$1,881 in reported general payments places this provider in the 90th percentile of 247 medical providers in Wisconsin.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcitriol | 27 | $331 |
| Doxazosin Mesylate | 15 | $212 |
| Amlodipine Besylate | 30 | $199 |
| Losartan Potassium | 22 | $193 |
| Lisinopril | 13 | $100 |
| Furosemide | 15 | $67 |
Paid to pharmacies, not to this prescriber.
Other medical in Neenah
- Jessica RobersNeenah$2K
- Rebecca BlankOnalaska$31K
- Amanda BreuerMadison$28K
- Anna BakerMilwaukee$26K
- Amber EssenmacherMilwaukee$21K
- Andrea MattisonKenosha$14K
- Tina SchnellJanesville$8K
- Savannah MatheMilwaukee$6K
- Patrick DrechslerWausau$5K
- Andrea GilbertsonMadison$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.